14 March
2024
BSF
Enterprise PLC
("BSF" or
the "Company")
BSF Investor
Evening
BSF Enterprise would like to welcome
current shareholders and interested investors to an Investor
Evening organised by Shard Capital Partners LLP on Tuesday, 19
March 2024.
At the event, a presentation will be
delivered by the management of BSF Enterprise, followed by a
Q&A session.
Hospitality will be
provided.
The event will take place at 1790
Bar, St Swithin's Lane, London from 17.30
To register your interest in
attending, please use the following link: https://forms.gle/FEmtcZT4mAA1DzS99
********************************************
Notes to Editors
About BSF Enterprise PLC:
BSF Enterprise PLC (BSF) is focused
on unlocking the next generation of biotechnological solutions -
using cell-based tissue engineering to help generate cultured meat,
lab-grown leather, as well as human corneas, collagen growth and
skin substitutes, as part of a radical transformation to deliver
sustainable solutions across a variety of sectors.
It owns 100% of 3D Bio-Tissues
(3DBT), a tissue engineering with patent-protected IP that is
already producing human corneas for testing to help restore vision
to millions of people. Building on this success, it aims to
produce the UK's first high quality leather from its
laboratory in Newcastle, transforming the leather industry towards
an ethical and sustainable practice.
BSF aims to deliver growth to
shareholders through the continued commercialisation of 3DBT's IP,
which has multiple applications, as well as through M&A. It
aims to develop a suite of technologies that underpins the
development of tissue templating for corneas, meat and leather, and
license out the IP to manufacturers, wholesalers and distributors
to help manufacture the products at scale.
|
--------------------------------------------------------------------
BSF Enterprise PLC
|
Via SEC Newgate below
|
|
Geoff Baker - Executive
Director
Che Connon - CEO &
Director
|
|
|
Shard Capital (Broker)
|
|
|
Damon Heath
Isabella Pierre
|
0207 186 9000
0207 186 9927
|
|
SEC Newgate (Financial
Communications)
|
|
|
Bob Huxford
Elisabeth Cowell
|
020 3757 6882
BSF@secnewgate.co.uk
|
ISIN of the Ordinary Shares
is GB00BHNBDQ51
SEDOL Code is BHNBDQ5.
